Lepu Biopharma (2157.HK) Earnings Analysis
Lepu Biopharma (2157.HK) next reports earnings on 2026-08-26. Trailing P/E 27.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2157.HK next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2157.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | 0.0267 HKD | n/a | n/a | n/a |
| 2024-12-31 | -0.13614 HKD | n/a | n/a | n/a |
| 2024-08-21 | -0.12386 HKD | n/a | n/a | n/a |
2157.HK valuation and analyst view
| Trailing P/E | 27.33 |
|---|---|
| Trailing EPS | 0.14277 HKD |
| Price / book | 5.14 |
| Dividend yield | 0.00% |
| Market cap | 8.77B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Lepu Biopharma (2157.HK)'s next earnings date?
Lepu Biopharma is next scheduled to report on 2026-08-26.
Did 2157.HK beat earnings last quarter?
Consensus estimate data was not available for 2157.HK's 2025-06-30 report.
What is 2157.HK's current P/E ratio and EPS?
2157.HK trades at a trailing P/E of 27.33 on trailing EPS of 0.14276721738513803 HKD.
What do analysts rate 2157.HK?
2157.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.